2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

Optimum Therapy for Standard Risk High Grade - DLBCL

By 2018 Pan Pacific Lymphoma Conference FEATURING Nancy L. Bartlett

280 views

August 15, 2018

Comments 0

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

The First Treatment Choice Matters

Feat. A. Ip

High Grade B-cell Lymphoma

Challenges of Treating HGBCL Patients with Comorbidities: Anthracycl…

2018 Pan Pacific Lymphoma Conference

L. Sehn

192 views

Optimum Therapy for Standard Risk High Grade - DLBCL

2018 Pan Pacific Lymphoma Conference

N. Bartlett

280 views

New Approaches to Initial treatment of DLBCL: R-CHOP +

2018 Pan Pacific Lymphoma Conference

N. Bartlett

551 views

Challenges of Treating HGBCL Patients with Comorbidities: Who is "FI…

2018 Pan Pacific Lymphoma Conference

L. Sehn

280 views

Burkitt Lymphoma- R-Epoch for All?

2018 Pan Pacific Lymphoma Conference

M. Roschewski

98 views

Concurrent Systemic and CNS Aggressive NHL: How to Manage?

2018 Pan Pacific Lymphoma Conference

P. Bierman

41 views

Therapy for Double/Triple Hit-HGBCL

2018 Pan Pacific Lymphoma Conference

S. Smith

218 views

There is a Role for Lymphoma HDT/ASCT in the New Era of CAR T-cells!

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

209 views

Is there a role for upfront transplantation in CNS Aggressive NHL

2018 Pan Pacific Lymphoma Conference

P. Bierman

27 views